Significantly Improved Cash Position and Balance SheetClosed Aevi Merger; Transformed into Orphan and Rare Disease BiotechROCKVILLE, Md., May 07, 2020 […]
Three Month ResultsNet revenue increased 5.8% to $406.6 millionNet income was $40.5 millionAdjusted EBITDA increased 9.4% to $159.8 millionThree Month […]
Significantly Improved Net Cash from Operating ActivitiesStrong Total Liquidity of $450 Million at Quarter EndMaintained Gross Margin Rate at Similar […]